10/2008

Life Sciences Newsletter October 2008

Publications

Supreme Court Examines Tort Claims Challenging Drug Warning Labels

You might also be interested in...

Client Alert
Recent $900 Million FCA Settlement Highlights Risks in Speaker Programs
Client Alert
30(b)(6) vs. 702 – Is Your Witness a Party or an Expert?
Authored Article
Guest Column: CFIUS Expansion into Agricultural Supply Chain and Genomics Tools